SOFIVA GENOMICS Co (ROCO:6615) Accounts Payable & Accrued Expense : NT$66.1 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co Accounts Payable & Accrued Expense?

SOFIVA GENOMICS Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (NT$62.3 Mil) to Dec. 2024 (NT$63.2 Mil) and increased from Dec. 2024 (NT$63.2 Mil) to Mar. 2025 (NT$66.1 Mil).

SOFIVA GENOMICS Co's annual accounts payable & accrued expense declined from Dec. 2022 (NT$96.5 Mil) to Dec. 2023 (NT$76.9 Mil) and declined from Dec. 2023 (NT$76.9 Mil) to Dec. 2024 (NT$63.2 Mil).

SOFIVA GENOMICS Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for SOFIVA GENOMICS Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOFIVA GENOMICS Co Accounts Payable & Accrued Expense Chart

SOFIVA GENOMICS Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

84.51

98.83

96.51

76.90

63.25

SOFIVA GENOMICS Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															71.10	69.03	62.27	63.25	66.06

SOFIVA GENOMICS Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

SOFIVA GENOMICS Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66-1, Section 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043

Website

https://www.sofivagenomics.com.tw

SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines